Form 8-K - Current report:
SEC Accession No. 0001493152-26-016294
Filing Date
2026-04-13
Accepted
2026-04-13 08:30:17
Documents
13
Period of Report
2026-04-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 41790
2 EX-99.1 ex99-1.htm EX-99.1 24987
3 GRAPHIC ex99-1_001.jpg GRAPHIC 33620
  Complete submission text file 0001493152-26-016294.txt   284998

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ogen-20260413.xsd EX-101.SCH 3017
5 XBRL LABEL FILE ogen-20260413_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE ogen-20260413_pre.xml EX-101.PRE 22360
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3245
Mailing Address 9015 TOWN CENTER PARKWAY SUITE 143 LAKEWOOD RANCH FL 34202
Business Address 9015 TOWN CENTER PARKWAY SUITE 143 LAKEWOOD RANCH FL 34202 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

EIN.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32188 | Film No.: 26856538
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)